Skip to main content
. Author manuscript; available in PMC: 2015 Mar 3.
Published in final edited form as: Lancet Neurol. 2014 Jul 30;13(9):893–903. doi: 10.1016/S1474-4422(14)70171-1

Table 1.

Post QC case/control numbers, as structured for analysis.

Index GWAS Ethnicity1 Epilepsy cases GGE Focal Population controls3
EPIGEN-Dublin Irish 638 - 520 2232
EPIGEN-Brussels Belgian 505 48 406 1675
EPIGEN-Duke AA2& EA 760 102 551 504
EPIGEN-London British + other 1007 93 773 2494
ILM Collaboration European-descent 1703 212 1263 2699
GenEpa Finnish 422 - 422 1963
EPICURE NW- European 1440 1440 - 2454
Philadelphia_550_AA2 African American 324 81 222 2746
Philadelphia_550_CAU European American 819 440 378 5736
Philadelphia_Omni_AA African American 106 - - 97
Philadelphia_Omni_CAU European American 485 190 288 682
Hong Kong Asian-Han 487 - 487 2875
TOTAL 8696 2606 5310 26157
1

Broad ethnicity of the cohort. AA: African American. EA: European American. Other: indicates mixed, as would be expected in a cosmopolitan population. European-descent: European-caucasian. NW-European: North-West European.

2

EPIGEN-Duke individuals of AA ancestry were merged with Philadelphia_550_AAcohort.

3

See Supplementary Table 2 for further details on control cohorts.

HHS Vulnerability Disclosure